Clinical Inquiries

What environmental modifications improve pediatric asthma?

Author and Disclosure Information

 

References

EVIDENCE-BASED ANSWER

Reducing environmental tobacco smoke exposure decreases health care utilization among poor asthmatic children. Dust mite reduction by chemical measures is potentially harmful. (Grade of recommendations: B, based on single randomized controlled trial.) Evidence is insufficient for or against dust mite reduction by physical means, use of synthetic or feather bedding, removal of cats, use of air filters or reducing indoor humidity. (Grade of recommendations: D, inconsistent studies.)

Evidence summary

Although several studies have shown the benefit of placing asthmatic and allergic children in highly sanitized hospital and sanitarium environments,1 benefit has been extremely difficult to prove with measures used in the child’s home. Only reducing tobacco smoke exposure has been shown to be beneficial. In a randomized trial of predominantly poor minority subjects, fewer acute asthma medical visits were needed by children whose household members underwent behavioral education aimed at decreasing smoke exposure.2

Other methods of modifying the environment have not proved beneficial. Although a group of researchers found that home visits by care providers may decrease acute medical visits, specific allergy avoidance steps did not make a difference.3 Two of these authors also reported that the use of chemicals for house dust mite control and the use of synthetic pillows in lieu of feather pillows may actually exacerbate asthma.4 A Cochrane review was inconclusive on the risks or benefits of feather bedding.5 Benefit from removing cats is difficult to prove because of the ubiquitous nature of cat antigen and the difficulty in eradicating it from the home. Using air filters and reducing indoor humidity have likewise failed to show meaningful improvement in peak flow, medication use, or symptom scores.

The effectiveness of physical methods to reduce house dust mites is unclear. The Cochrane Review of 15 trials noted a small, statistically significant improvement in asthma symptom scores, but the results were not clinically important enough to recommend such measures.6 The potential harm of chemical measures was reiterated in this review.

TABLE
Environmental modifications for children with asthma

InterventionEffect
Tobacco smoke exposure reductionBeneficial
Chemical reduction of dust mitesHarmful
Physical reduction of dust mitesUnknown
Bedding material (feather vs synthetic)Unknown
Removal of catsUnknown
Air filters or dehumidificationUnknown

Recommendations from others

The National Heart, Lung, and Blood Institute continues to recommend physical barriers to reduce house dust mite antigen based on 4 small trials in which the major benefit was decreased bronchial hyperresponsiveness.7 Larger trials, now under way, may help resolve the issue.

Clinical Commentary by Nicholas J. Solomos, MD, at http://www.fpin.org.

Evidence-based answers from the Family Physicians Inquiries Network

Recommended Reading

How often is coughing the presenting complaint in patients with gastroesophageal reflux disease?
MDedge Family Medicine
In children hospitalized for asthma exacerbations, does adding ipratropium bromide to albuterol and corticosteroids improve outcome?
MDedge Family Medicine
Is budesonide or nedocromil superior in the long-term management of mild to moderate asthma in children?
MDedge Family Medicine
Fluticasone Propionate Compared with Zafirlukast in Controlling Persistent Asthma A Randomized Double-Blind, Placebo-Controlled Trial
MDedge Family Medicine
In patients with asthma that is not well controlled with inhaled steroids, does salmeterol (Serevent) or montelukast (Singulair) offer better symptom relief?
MDedge Family Medicine
Is a 2-day course of oral dexamethasone more effective than 5 days of oral prednisone in improving symptoms and preventing relapse in children with acute asthma?
MDedge Family Medicine
In children with asthma, do inhaled steroids reduce linear growth (height)?
MDedge Family Medicine
Do African American asthmatics perceive and describe their asthma symptoms differently than white asthmatics?
MDedge Family Medicine
Is there a clinical difference in outcomes when b-agonist therapy is delivered through metered-dose inhaler (MDI) with a spacing device compared with standard nebulizer treatments in acutely wheezing children?
MDedge Family Medicine
Does exposure of young children to older siblings or to children at day-care facilities protect against the development of asthma later in childhood?
MDedge Family Medicine